Yoo, Byunghee
Jordan, Veronica Clavijo
Sheedy, Patrick http://orcid.org/0000-0001-7113-6018
Billig, Ann-Marie
Ross, Alana
Pantazopoulos, Pamela
Medarova, Zdravka
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1R01CA221771-01A1)
Article History
Received: 14 August 2018
Accepted: 5 March 2019
First Online: 18 March 2019
Competing Interests
: Zdravka Medarova is Founder and Scientific Advisory Board Member of TransCode Therapeutics, Inc.